🩸 Ep 9 - Prof Mark Yazer – “Bag the Saline. Bring the Blood.” All things blood transfusion

Keywords Transfusion medicine, pre-hospital care, blood products, PAMPer trial, whole blood, crystalloids, transfusion reactions, trauma care, blood delivery, research outcomes Summary In this engaging conversation, Matt Shepherd and Alex Olaussen discuss the intricacies of transfusion medicine with expert Prof Mark Yaser. They delve into the PAMPer trial (which Prof Yazer was a key part of), the importance of pre-hospital blood transfusions, and the various types of blood products available. Mark shares insights on the role of crystalloids, the management of transfusion reactions, and the significance of timely blood administration in trauma care. The discussion also touches on the future of blood delivery through drones and the challenges of research outcomes in transfusion medicine. Takeaways The PAMPer trial demonstrated better outcomes with plasma transfusions. Whole blood provides balanced resuscitation for trauma patients. Crystalloids may not be beneficial in trauma care. Transfusion reactions are often mild and manageable. Timely blood administration can significantly impact survival rates. Drones may revolutionize blood delivery in the future. Research outcomes should focus on early survival rates. Whole blood is preferred for unknown patient conditions. Transport time is critical in pre-hospital care. Collaboration across specialties enhances patient care. Links: https://www.nejm.org/doi/full/10.1056... Chapters 00:00 Introduction to Transfusion Medicine 03:03 The PAMPer Trial and Pre-Hospital Blood Transfusions 06:11 Understanding Blood Products 08:56 Whole Blood vs. Component Therapy 11:50 The Role of Crystalloids in Trauma Care 15:01 Temperature Control and Blood Transport 17:50 Future Directions in Pre-Hospital Blood Transfusion 30:45 Hollywood and Whole Blood: A Unique Connection 32:10 The Future of Drone Delivery in Healthcare 35:12 The Importance of Pre-Hospital Blood Transfusion 40:02 Understanding Blood Transfusion Reactions 49:19 Research Outcomes in Blood Transfusion Trials